510(k) DEN170058 ยท PZM Next Generation Sequencing Based Tumor Profiling Test
MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets):a Hybridization-Capture Based Next Generation Sequencing Assay
| Applicant | Memorial Sloan-Kettering Cancer Center, New York NY, US |
| Decision | Unknown, Nov 15, 2017 |
| Received | Sep 25, 2017 |
| Type | Direct |
| FDA record | Open on fda.gov |
Recalls that name DEN170058
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.